市場調査レポート

商品コード

1139839

陽子線治療市場：適応症別、製品タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Proton Therapy Market By Indication, By Product Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: 2022年06月01日 | 発行: Allied Market Research

| ページ情報: 英文 150 Pages | 納期: 2～3営業日

価格

Cloud Access (Single User License)

USD 3,456 543,075円

レポートのクラウドアクセスでご利用頂けるライセンスです。ウェブポータルで配信され、60日間レポートにアクセスできます。この期間を過ぎるとレポートへのアクセスは失効します。コンテンツのダウンロード、印刷、共有、コピー＆ペーストはできません。

PDF (Business License)

USD 5,769 906,540円

レポートPDFをご利用いただけるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDFl内のテキスト等のコピー＆ペーストは可能です。印刷は5回可能です。追加料金を支払うことで、2～5ユーザーを収容できるようにアップグレードできます。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 10,995 1,727,754円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の陽子線治療市場は、2021年に4億3833万米ドル、2022年から2031年にかけてCAGR13.65%を記録し、2031年には15億7,939万米ドルに達すると予測されています。

陽子線治療は、最も精密で高度な放射線治療の一種です。癌の治療に広く利用されています。陽子線治療は、従来の放射線治療と比較して、効果や副作用の面で多くの優位性を持っています。陽子線治療は快適で非侵襲的な治療法であり、患者のQOLを維持し、通常の活動に早く戻れるようにします。健康な組織や臓器に害を与えることなく、原発性腫瘍を死滅させるために、医師が全線量またはそれ以上の治療量を投与することが可能です。光子療法や他の粒子線治療の主な制限は、陽子線治療によって克服されます。技術の進歩により、世界中で様々な癌の治療に陽子線治療が採用されるようになりました。

陽子線治療に対する需要は、がん罹患率の増加、陽子線治療の利点に関する啓蒙活動の急増、放射線治療装置の技術進歩により、予測期間中に世界中で増加すると予想されます。また、陽子線治療に対する患者の関心も高く、陽子線治療の認知度が向上していることも、市場の成長を後押ししています。しかし、陽子線治療のコストは高く、市場成長の妨げになると予想されます。また、陽子線治療器はサイズが非常に大きく、専用の広いスペースが必要です。また、陽子線治療装置の設置費用は装置費用とは別にかかるため、投資額がさらに増加し、市場の成長を抑制する要因となっています。さらに、新興国における陽子線治療の導入は、同市場の主要プレイヤーに有利な成長機会を提供すると期待されています。

概要
- 市場規模および予測
頭頸部がん
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
中枢神経系癌
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
前立腺癌
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
乳がん
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第5章陽子線治療市場：製品タイプ別

概要
- 市場規模・予測
アクセラレータ
- 主な市場動向、成長要因と機会
- 市場規模・予測：地域別
- 市場分析：国別分析
ビーム輸送系
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
ビーム伝送装置
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
ノズルと画像ビューア
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
患者位置決めシステム
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第6章陽子線治療市場：エンドユーザー別

概要
- 市場規模・予測
病院
- 主な市場動向、成長要因と機会
- 市場規模・予測：地域別
- 市場分析：国別
陽子線治療センター
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第7章陽子線治療市場：地域別

概要
- 市場規模・予測
北米
- 主な動向と機会
- 北米市場規模・予測：適応症別
- 北米市場規模・予測：製品タイプ別
- 北米市場規模・予測：エンドユーザー別
- 北米市場規模・予測：国別
  - 米国
欧州
- 主要動向と機会
- 欧州市場規模・予測：適応症別
- 欧州市場規模・予測：製品タイプ別
- 欧州市場規模・予測：エンドユーザー別
- 欧州市場規模・予測：国別
  - ドイツ
  - フランス
  - 英国
  - その他欧州地域
アジア太平洋地域
- 主な動向と機会
- アジア太平洋地域の市場規模・予測：適応症別
- アジア太平洋地域の市場規模・予測：製品タイプ別
- アジア太平洋地域の市場規模・予測：エンドユーザー別
- アジア太平洋地域の市場規模・予測：国別
  - 日本
  - 中国
  - 韓国
  - その他アジア太平洋地域
LAMEA
- 主な動向と機会
- LAMEAの市場規模・予測：適応症別
- LAMEAの市場規模・予測：製品タイプ別
- LAMEAの市場規模・予測：エンドユーザー別
- LAMEAの市場規模・予測：国別
  - サウジアラビア

第8章企業情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合のヒートマップ
主な発展

第9章企業プロファイル

ION BEAM APPLICATIONS
Provision Healthcare
HITACHI LTD.
MEVION MEDICAL SYSTEMS
OPTIVUS PROTON THERAPY INC.
PRONOVA SOLUTIONS LLC.
SUMITOMO CORPORATION
Siemens Ltd
Mirion Technologies
Toshiba Corp.

図表

LIST OF TABLES

TABLE 1. GLOBAL PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 2. PROTON THERAPY MARKET REVENUE, FOR HEAD AND NECK CANCER, BY REGION , 2021-2031,($MILLION)
TABLE 3. PROTON THERAPY MARKET FOR HEAD AND NECK CANCER BY COUNTRY, 2021-2031,($MILLION)
TABLE 4. PROTON THERAPY MARKET REVENUE, FOR CNS CANCER, BY REGION , 2021-2031,($MILLION)
TABLE 5. PROTON THERAPY MARKET FOR CNS CANCER BY COUNTRY, 2021-2031,($MILLION)
TABLE 6. PROTON THERAPY MARKET REVENUE, FOR PROSTATE CANCER, BY REGION , 2021-2031,($MILLION)
TABLE 7. PROTON THERAPY MARKET FOR PROSTATE CANCER BY COUNTRY, 2021-2031,($MILLION)
TABLE 8. PROTON THERAPY MARKET REVENUE, FOR BREAST CANCER, BY REGION , 2021-2031,($MILLION)
TABLE 9. PROTON THERAPY MARKET FOR BREAST CANCER BY COUNTRY, 2021-2031,($MILLION)
TABLE 10. PROTON THERAPY MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
TABLE 11. PROTON THERAPY MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 12. GLOBAL PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 13. PROTON THERAPY MARKET REVENUE, FOR ACCELERATOR, BY REGION , 2021-2031,($MILLION)
TABLE 14. PROTON THERAPY MARKET FOR ACCELERATOR BY COUNTRY, 2021-2031,($MILLION)
TABLE 15. PROTON THERAPY MARKET REVENUE, FOR BEAM TRANSPORT SYSTEM, BY REGION , 2021-2031,($MILLION)
TABLE 16. PROTON THERAPY MARKET FOR BEAM TRANSPORT SYSTEM BY COUNTRY, 2021-2031,($MILLION)
TABLE 17. PROTON THERAPY MARKET REVENUE, FOR BEAM DELIVERY SYSTEM, BY REGION , 2021-2031,($MILLION)
TABLE 18. PROTON THERAPY MARKET FOR BEAM DELIVERY SYSTEM BY COUNTRY, 2021-2031,($MILLION)
TABLE 19. PROTON THERAPY MARKET REVENUE, FOR NOZZLE AND IMAGE VIEWERS, BY REGION , 2021-2031,($MILLION)
TABLE 20. PROTON THERAPY MARKET FOR NOZZLE AND IMAGE VIEWERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 21. PROTON THERAPY MARKET REVENUE, FOR PATIENT POSITIONING SYSTEM, BY REGION , 2021-2031,($MILLION)
TABLE 22. PROTON THERAPY MARKET FOR PATIENT POSITIONING SYSTEM BY COUNTRY, 2021-2031,($MILLION)
TABLE 23. GLOBAL PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 24. PROTON THERAPY MARKET REVENUE, FOR HOSPITALS, BY REGION , 2021-2031,($MILLION)
TABLE 25. PROTON THERAPY MARKET FOR HOSPITALS BY COUNTRY, 2021-2031,($MILLION)
TABLE 26. PROTON THERAPY MARKET REVENUE, FOR PROTON THERAPY CENTERS, BY REGION , 2021-2031,($MILLION)
TABLE 27. PROTON THERAPY MARKET FOR PROTON THERAPY CENTERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 28. PROTON THERAPY MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
TABLE 29. PROTON THERAPY MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
TABLE 30. PROTON THERAPY MARKET, BY REGION, 2021-2031,($MILLION)
TABLE 31. NORTH AMERICA PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 32. NORTH AMERICA PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 33. NORTH AMERICA PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 34. NORTH AMERICA PROTON THERAPY MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 35. U.S. PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 36. U.S. PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 37. U.S. PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 38. EUROPE PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 39. EUROPE PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 40. EUROPE PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 41. EUROPE PROTON THERAPY MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 42. GERMANY PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 43. GERMANY PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 44. GERMANY PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 45. FRANCE PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 46. FRANCE PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 47. FRANCE PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 48. U.K. PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 49. U.K. PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 50. U.K. PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 51. REST OF EUROPE PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 52. REST OF EUROPE PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 53. REST OF EUROPE PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 54. ASIA-PACIFIC PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 55. ASIA-PACIFIC PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 56. ASIA-PACIFIC PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 57. ASIA-PACIFIC PROTON THERAPY MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 58. JAPAN PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 59. JAPAN PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 60. JAPAN PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 61. CHINA PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 62. CHINA PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 63. CHINA PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 64. SOUTH KOREA PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 65. SOUTH KOREA PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 66. SOUTH KOREA PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 67. REST OF ASIA-PACIFIC PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 68. REST OF ASIA-PACIFIC PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 69. REST OF ASIA-PACIFIC PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 70. LAMEA PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 71. LAMEA PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 72. LAMEA PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 73. LAMEA PROTON THERAPY MARKET, BY COUNTRY, 2021-2031,($MILLION)
TABLE 74. SAUDI ARABIA PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
TABLE 75. SAUDI ARABIA PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
TABLE 76. SAUDI ARABIA PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
TABLE 77.ION BEAM APPLICATIONS: COMPANY SNAPSHOT
TABLE 78.ION BEAM APPLICATIONS: OPERATING SEGMENTS
TABLE 79.ION BEAM APPLICATIONS: PRODUCT PORTFOLIO
TABLE 80.ION BEAM APPLICATIONS: NET SALES,
TABLE 81.ION BEAM APPLICATIONS: KEY STRATERGIES
TABLE 82.PROVISION HEALTHCARE: COMPANY SNAPSHOT
TABLE 83.PROVISION HEALTHCARE: OPERATING SEGMENTS
TABLE 84.PROVISION HEALTHCARE: PRODUCT PORTFOLIO
TABLE 85.PROVISION HEALTHCARE: NET SALES,
TABLE 86.PROVISION HEALTHCARE: KEY STRATERGIES
TABLE 87.HITACHI LTD.: COMPANY SNAPSHOT
TABLE 88.HITACHI LTD.: OPERATING SEGMENTS
TABLE 89.HITACHI LTD.: PRODUCT PORTFOLIO
TABLE 90.HITACHI LTD.: NET SALES,
TABLE 91.HITACHI LTD.: KEY STRATERGIES
TABLE 92.MEVION MEDICAL SYSTEMS: COMPANY SNAPSHOT
TABLE 93.MEVION MEDICAL SYSTEMS: OPERATING SEGMENTS
TABLE 94.MEVION MEDICAL SYSTEMS: PRODUCT PORTFOLIO
TABLE 95.MEVION MEDICAL SYSTEMS: NET SALES,
TABLE 96.MEVION MEDICAL SYSTEMS: KEY STRATERGIES
TABLE 97.OPTIVUS PROTON THERAPY INC.: COMPANY SNAPSHOT
TABLE 98.OPTIVUS PROTON THERAPY INC.: OPERATING SEGMENTS
TABLE 99.OPTIVUS PROTON THERAPY INC.: PRODUCT PORTFOLIO
TABLE 100.OPTIVUS PROTON THERAPY INC.: NET SALES,
TABLE 101.OPTIVUS PROTON THERAPY INC.: KEY STRATERGIES
TABLE 102.PRONOVA SOLUTIONS LLC.: COMPANY SNAPSHOT
TABLE 103.PRONOVA SOLUTIONS LLC.: OPERATING SEGMENTS
TABLE 104.PRONOVA SOLUTIONS LLC.: PRODUCT PORTFOLIO
TABLE 105.PRONOVA SOLUTIONS LLC.: NET SALES,
TABLE 106.PRONOVA SOLUTIONS LLC.: KEY STRATERGIES
TABLE 107.SUMITOMO CORPORATION: COMPANY SNAPSHOT
TABLE 108.SUMITOMO CORPORATION: OPERATING SEGMENTS
TABLE 109.SUMITOMO CORPORATION: PRODUCT PORTFOLIO
TABLE 110.SUMITOMO CORPORATION: NET SALES,
TABLE 111.SUMITOMO CORPORATION: KEY STRATERGIES
TABLE 112.SIEMENS LTD: COMPANY SNAPSHOT
TABLE 113.SIEMENS LTD: OPERATING SEGMENTS
TABLE 114.SIEMENS LTD: PRODUCT PORTFOLIO
TABLE 115.SIEMENS LTD: NET SALES,
TABLE 116.SIEMENS LTD: KEY STRATERGIES
TABLE 117.MIRION TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 118.MIRION TECHNOLOGIES: OPERATING SEGMENTS
TABLE 119.MIRION TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 120.MIRION TECHNOLOGIES: NET SALES,
TABLE 121.MIRION TECHNOLOGIES: KEY STRATERGIES
TABLE 122.TOSHIBA CORP.: COMPANY SNAPSHOT
TABLE 123.TOSHIBA CORP.: OPERATING SEGMENTS
TABLE 124.TOSHIBA CORP.: PRODUCT PORTFOLIO
TABLE 125.TOSHIBA CORP.: NET SALES,
TABLE 126.TOSHIBA CORP.: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.PROTON THERAPY MARKET SEGMENTATION
FIGURE 2.PROTON THERAPY MARKET,2021-2031
FIGURE 3.PROTON THERAPY MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.PROTON THERAPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.PROTON THERAPY MARKET,BY INDICATION,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF HEAD AND NECK CANCER PROTON THERAPY MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF CNS CANCER PROTON THERAPY MARKET,2021-2031(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PROSTATE CANCER PROTON THERAPY MARKET,2021-2031(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BREAST CANCER PROTON THERAPY MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS PROTON THERAPY MARKET,2021-2031(%)
FIGURE 18.PROTON THERAPY MARKET,BY PRODUCT TYPE,2021(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ACCELERATOR PROTON THERAPY MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF BEAM TRANSPORT SYSTEM PROTON THERAPY MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF BEAM DELIVERY SYSTEM PROTON THERAPY MARKET,2021-2031(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF NOZZLE AND IMAGE VIEWERS PROTON THERAPY MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PATIENT POSITIONING SYSTEM PROTON THERAPY MARKET,2021-2031(%)
FIGURE 24.PROTON THERAPY MARKET,BY END USER,2021(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF HOSPITALS PROTON THERAPY MARKET,2021-2031(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF PROTON THERAPY CENTERS PROTON THERAPY MARKET,2021-2031(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS PROTON THERAPY MARKET,2021-2031(%)
FIGURE 28.PROTON THERAPY MARKET BY REGION,2021
FIGURE 29.U.S. PROTON THERAPY MARKET,2021-2031($MILLION)
FIGURE 30.GERMANY PROTON THERAPY MARKET,2021-2031($MILLION)
FIGURE 31.FRANCE PROTON THERAPY MARKET,2021-2031($MILLION)
FIGURE 32.U.K. PROTON THERAPY MARKET,2021-2031($MILLION)
FIGURE 33.REST OF EUROPE PROTON THERAPY MARKET,2021-2031($MILLION)
FIGURE 34.JAPAN PROTON THERAPY MARKET,2021-2031($MILLION)
FIGURE 35.CHINA PROTON THERAPY MARKET,2021-2031($MILLION)
FIGURE 36.SOUTH KOREA PROTON THERAPY MARKET,2021-2031($MILLION)
FIGURE 37.REST OF ASIA-PACIFIC PROTON THERAPY MARKET,2021-2031($MILLION)
FIGURE 38.SAUDI ARABIA PROTON THERAPY MARKET,2021-2031($MILLION)
FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 42.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 43.COMPETITIVE DASHBOARD
FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 45.ION BEAM APPLICATIONS.: NET SALES ,($MILLION)
FIGURE 46.PROVISION HEALTHCARE.: NET SALES ,($MILLION)
FIGURE 47.HITACHI LTD..: NET SALES ,($MILLION)
FIGURE 48.MEVION MEDICAL SYSTEMS.: NET SALES ,($MILLION)
FIGURE 49.OPTIVUS PROTON THERAPY INC..: NET SALES ,($MILLION)
FIGURE 50.PRONOVA SOLUTIONS LLC..: NET SALES ,($MILLION)
FIGURE 51.SUMITOMO CORPORATION.: NET SALES ,($MILLION)
FIGURE 52.SIEMENS LTD.: NET SALES ,($MILLION)
FIGURE 53.MIRION TECHNOLOGIES.: NET SALES ,($MILLION)
FIGURE 54.TOSHIBA CORP..: NET SALES ,($MILLION)

Product Code: A00427

The global proton therapy market was valued at $438.33 million in 2021, and is projected to reach $1579.39 million by 2031, registering a CAGR of 13.65% from 2022 to 2031.

Proton therapy is the most precise and advanced type of radiation therapy. It is widely used to treat cancer. It has a number of advantages over traditional radiation therapy, in terms of efficacy and adverse effects. It is a pleasant, non-invasive treatment that helps patients retain their quality of life and return to normal activities fast. It enables doctors to administer full or greater treatment dosages that kill primary tumors without harming healthy tissues or organs. Major limitations of photon therapy or other particle therapies are overcome by proton therapy. Advancements in technology have increased adoption of proton therapy for treatments of various cancers across the globe.

Demand for proton therapy is anticipated to increase globally during the forecast period, owing to increase in prevalence of cancer and surge in number of awareness campaigns about benefits of proton therapy and technological advancements in radiotherapy devices. Moreover, patients are eager to know more about proton therapy treatment process and increase in recognition of proton therapy drive growth of the market, globally. However, higher cost of proton therapy is anticipated to hamper the market growth. In addition, proton therapy devices are very large in size and require large space with dedicated areas. The setup cost is exclusive of the device cost, which further increases investments, thereby restraining growth of this market. Moreover, introduction of proton therapy in emerging economies is expected to offer lucrative growth opportunities for key players in the market.

The global proton therapy market is segmented into indications, product type, end user, and region. By indication, the market is divided into head & neck cancer, central nervous system cancer, prostate cancer, breast cancer, and others. According to product type, it is bifurcated into accelerator, beam transport system, beam delivery system, nozzles & image viewers, and patient positioning system. On the basis of end user market, it is divided into hospitals, proton therapy centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Major companies profiled in the report include Hitachi, Ltd., Ion Beam Applications S.A., Mevion Medical Systems, Mirion Technologies Ltd., Optivus Proton Therapy, Inc., Provision Healthcare, Pro Tom International, Siemens, Sumitomo Heavy Industries, Ltd., and Toshiba Corporation.

Key Benefits For Stakeholders

This report provides an in-depth analysis of the proton therapy market with current trends and estimations from 2022 to 2031.

Geographical analysis of the market is expected to help companies to plan their strategies accordingly and take region specific decisions.

Analysis of key strategies adopted by market players is expected to provide market intelligence and help stakeholders understand competitive structure of the market.

The report analyzes market conditions in a comprehensive and quantitative manner and forecasts market trends and techniques for proton therapy applications.

Key Market Segments

By Indication

Head and Neck Cancer
CNS Cancer
Prostate Cancer
Breast Cancer
Others

By Product Type

Accelerator
Beam Transport System
Beam Delivery System
Nozzle and Image Viewers
Patient Positioning System

By End User

Hospitals
Proton Therapy Centers
Others

By Region

North America
- U.S.
Europe
- Germany
- France
- U.K.
- Rest of Europe
Asia-Pacific
- Japan
- China
- South Korea
- Rest of Asia-Pacific
LAMEA
- Saudi Arabia
Key Market Players
- ION BEAM APPLICATIONS
- Provision Healthcare
- HITACHI LTD.
- MEVION MEDICAL SYSTEMS
- OPTIVUS PROTON THERAPY INC.
- PRONOVA SOLUTIONS LLC.
- SUMITOMO CORPORATION
- Siemens Ltd
- Mirion Technologies
- Toshiba Corp.

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: PROTON THERAPY MARKET, BY INDICATION

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Head and Neck Cancer
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 CNS Cancer
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
4.4 Prostate Cancer
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
4.5 Breast Cancer
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
4.6 Others
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country

CHAPTER 5: PROTON THERAPY MARKET, BY PRODUCT TYPE

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Accelerator
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Beam Transport System
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Beam Delivery System
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Nozzle and Image Viewers
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
5.6 Patient Positioning System
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country

CHAPTER 6: PROTON THERAPY MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Proton Therapy Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country

CHAPTER 7: PROTON THERAPY MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Indication
- 7.2.3 North America Market size and forecast, by Product Type
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Indication
  - 7.2.5.1.2 Market size and forecast, by Product Type
  - 7.2.5.1.3 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Indication
- 7.3.3 Europe Market size and forecast, by Product Type
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Indication
  - 7.3.5.1.2 Market size and forecast, by Product Type
  - 7.3.5.1.3 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Indication
  - 7.3.5.2.2 Market size and forecast, by Product Type
  - 7.3.5.2.3 Market size and forecast, by End User
  - 7.3.5.3 U.K.
  - 7.3.5.3.1 Market size and forecast, by Indication
  - 7.3.5.3.2 Market size and forecast, by Product Type
  - 7.3.5.3.3 Market size and forecast, by End User
  - 7.3.5.4 Rest of Europe
  - 7.3.5.4.1 Market size and forecast, by Indication
  - 7.3.5.4.2 Market size and forecast, by Product Type
  - 7.3.5.4.3 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Indication
- 7.4.3 Asia-Pacific Market size and forecast, by Product Type
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Market size and forecast, by Indication
  - 7.4.5.1.2 Market size and forecast, by Product Type
  - 7.4.5.1.3 Market size and forecast, by End User
  - 7.4.5.2 China
  - 7.4.5.2.1 Market size and forecast, by Indication
  - 7.4.5.2.2 Market size and forecast, by Product Type
  - 7.4.5.2.3 Market size and forecast, by End User
  - 7.4.5.3 South Korea
  - 7.4.5.3.1 Market size and forecast, by Indication
  - 7.4.5.3.2 Market size and forecast, by Product Type
  - 7.4.5.3.3 Market size and forecast, by End User
  - 7.4.5.4 Rest of Asia-Pacific
  - 7.4.5.4.1 Market size and forecast, by Indication
  - 7.4.5.4.2 Market size and forecast, by Product Type
  - 7.4.5.4.3 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Indication
- 7.5.3 LAMEA Market size and forecast, by Product Type
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Saudi Arabia
  - 7.5.5.1.1 Market size and forecast, by Indication
  - 7.5.5.1.2 Market size and forecast, by Product Type
  - 7.5.5.1.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 ION BEAM APPLICATIONS
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 Provision Healthcare
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 HITACHI LTD.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 MEVION MEDICAL SYSTEMS
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 OPTIVUS PROTON THERAPY INC.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 PRONOVA SOLUTIONS LLC.
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 SUMITOMO CORPORATION
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 Siemens Ltd
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Mirion Technologies
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 Toshiba Corp.
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments

陽子線治療市場：適応症別、製品タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Proton Therapy Market By Indication, By Product Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章陽子線治療市場：適応症別

第5章陽子線治療市場：製品タイプ別

第6章陽子線治療市場：エンドユーザー別

第7章陽子線治療市場：地域別

第8章企業情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: PROTON THERAPY MARKET, BY INDICATION

CHAPTER 5: PROTON THERAPY MARKET, BY PRODUCT TYPE

CHAPTER 6: PROTON THERAPY MARKET, BY END USER

CHAPTER 7: PROTON THERAPY MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

陽子線治療市場：適応症別、製品タイプ別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Proton Therapy Market By Indication, By Product Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

第4章 陽子線治療市場：適応症別

第5章 陽子線治療市場：製品タイプ別

第6章 陽子線治療市場：エンドユーザー別

第7章 陽子線治療市場：地域別

第8章 企業情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: PROTON THERAPY MARKET, BY INDICATION

CHAPTER 5: PROTON THERAPY MARKET, BY PRODUCT TYPE

CHAPTER 6: PROTON THERAPY MARKET, BY END USER

CHAPTER 7: PROTON THERAPY MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章陽子線治療市場：適応症別

第5章陽子線治療市場：製品タイプ別

第6章陽子線治療市場：エンドユーザー別

第7章陽子線治療市場：地域別

第8章企業情勢

第9章企業プロファイル